211 related articles for article (PubMed ID: 18722373)
1. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
Ladu S; Calvisi DF; Conner EA; Farina M; Factor VM; Thorgeirsson SS
Gastroenterology; 2008 Oct; 135(4):1322-32. PubMed ID: 18722373
[TBL] [Abstract][Full Text] [Related]
2. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway.
Yu Y; Zhao D; Li K; Cai Y; Xu P; Li R; Li J; Chen X; Chen P; Cui G
Cell Death Dis; 2020 Apr; 11(4):273. PubMed ID: 32332880
[TBL] [Abstract][Full Text] [Related]
3. The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway.
Qiao L; Zhang Q; Sun Z; Liu Q; Wu Z; Hu W; Bao S; Yang Q; Liu L
Cancer Lett; 2021 Aug; 514():63-78. PubMed ID: 34044068
[TBL] [Abstract][Full Text] [Related]
4. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
[TBL] [Abstract][Full Text] [Related]
5. Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.
Xu H; Chen K; Shang R; Chen X; Zhang Y; Song X; Evert M; Zhong S; Li B; Calvisi DF; Chen X
Cell Death Dis; 2021 Oct; 12(10):920. PubMed ID: 34625531
[TBL] [Abstract][Full Text] [Related]
6. The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans.
Xu Z; Xu M; Liu P; Zhang S; Shang R; Qiao Y; Che L; Ribback S; Cigliano A; Evert K; Pascale RM; Dombrowski F; Evert M; Chen X; Calvisi DF; Chen X
Hepatology; 2019 Nov; 70(5):1600-1613. PubMed ID: 31062368
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
Chen H; Cai W; Chu ESH; Tang J; Wong CC; Wong SH; Sun W; Liang Q; Fang J; Sun Z; Yu J
Oncogene; 2017 Aug; 36(31):4415-4426. PubMed ID: 28346420
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
Li L; Pilo GM; Li X; Cigliano A; Latte G; Che L; Joseph C; Mela M; Wang C; Jiang L; Ribback S; Simile MM; Pascale RM; Dombrowski F; Evert M; Semenkovich CF; Chen X; Calvisi DF
J Hepatol; 2016 Feb; 64(2):333-341. PubMed ID: 26476289
[TBL] [Abstract][Full Text] [Related]
9. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
Allen-Petersen BL; Risom T; Feng Z; Wang Z; Jenny ZP; Thoma MC; Pelz KR; Morton JP; Sansom OJ; Lopez CD; Sheppard B; Christensen DJ; Ohlmeyer M; Narla G; Sears RC
Cancer Res; 2019 Jan; 79(1):209-219. PubMed ID: 30389701
[TBL] [Abstract][Full Text] [Related]
10. TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Yu J; Ling S; Hong J; Zhang L; Zhou W; Yin L; Xu S; Que Q; Wu Y; Zhan Q; Bao J; Xu N; Liu Y; Chen K; Wei X; Liu Z; Feng T; Zhou L; Xie H; Wang S; Liu J; Zheng S; Xu X
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030304
[TBL] [Abstract][Full Text] [Related]
11. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
[TBL] [Abstract][Full Text] [Related]
12. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma.
Castellano GM; Zeeshan S; Garbuzenko OB; Sabaawy HE; Malhotra J; Minko T; Pine SR
Mol Cancer Ther; 2022 Sep; 21(9):1381-1392. PubMed ID: 35732569
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.
Choiniere J; Wu J; Wang L
Mol Pharmacol; 2017 Mar; 91(3):189-196. PubMed ID: 28003426
[TBL] [Abstract][Full Text] [Related]
15. Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.
Tao J; Ji J; Li X; Ding N; Wu H; Liu Y; Wang XW; Calvisi DF; Song G; Chen X
Oncotarget; 2015 Mar; 6(9):6977-88. PubMed ID: 25762642
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.
Liu X; Song X; Zhang J; Xu Z; Che L; Qiao Y; Ortiz Pedraza Y; Cigliano A; Pascale RM; Calvisi DF; Liu Y; Chen X
Cancer Med; 2018 Dec; 7(12):6170-6181. PubMed ID: 30370649
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between autophagy inhibitor and salidroside-induced apoptosis: A novel strategy for autophagy-based treatment of hepatocellular cancer.
Jiang B; Cui Y; Ma X; Zhang Y; Feng X; Yang T; Feng L; Guo W; Li Y; Wang T; Guo H; Li H; Duan Y; Su H
Int Immunopharmacol; 2023 Nov; 124(Pt B):111040. PubMed ID: 37839277
[TBL] [Abstract][Full Text] [Related]
18. The splicing regulatory factor hnRNPU is a novel transcriptional target of c-Myc in hepatocellular carcinoma.
Zhang B; Wang HY; Zhao DX; Wang DX; Zeng Q; Xi JF; Nan X; He LJ; Zhou JN; Pei XT; Yue W
FEBS Lett; 2021 Jan; 595(1):68-84. PubMed ID: 33040326
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.
Wang C; Delogu S; Ho C; Lee SA; Gui B; Jiang L; Ladu S; Cigliano A; Dombrowski F; Evert M; Calvisi DF; Chen X
J Hepatol; 2012 Sep; 57(3):577-83. PubMed ID: 22617155
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
